Invention Grant
- Patent Title: 2,7-diazaspiro[3.5]nonane compounds
-
Application No.: US15433164Application Date: 2017-02-15
-
Publication No.: US09750745B2Publication Date: 2017-09-05
- Inventor: Gerard Griffioen , Bart De Taeye , Katrien Princen , Koen De Witte , Emilie Blanche , Hasane Ratni , Mark Rogers-Evans
- Applicant: REMYND NV
- Applicant Address: BE Heverlee
- Assignee: REMYND NV
- Current Assignee: REMYND NV
- Current Assignee Address: BE Heverlee
- Agency: Amster, Rothstein & Ebenstein LLP
- Priority: EP14160344 20140317
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; A61K31/435 ; A61K31/444
![2,7-diazaspiro[3.5]nonane compounds](/abs-image/US/2017/09/05/US09750745B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to a compound of formula (I) or a stereoisomer, enantiomer, racemic, or tautomer thereof, Formula (I), wherein R1, R3, R4, L1, L2, L3, L4, and n, have the same meaning as that defined in the claims and the description. The present invention also relates to compositions, in particular pharmaceuticals, comprising such compounds, and to uses of such compounds and compositions for the prevention and/or treatment of metabolic disorders and/or neurodegenerative diseases, and/or protein misfolding disorders.
Public/Granted literature
- US20170157137A1 2,7-DIAZASPIRO[3.5]NONANE COMPOUNDS Public/Granted day:2017-06-08
Information query
IPC分类: